Pulling SEC filings + quote and writing the call…
TFX
TELEFLEX INC
Next earnings Jul 29, 2026 (before open) · consensus $1.28 EPS, $565M rev
$127.00
▲ +1.63%$127.00▲ +6.06%
over 1Y
L $99.79EODHDH $138.45
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+1.6%
1W-1.8%
1M-4.1%
3M+18.9%
YTD+4.3%
1Y+6.1%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 17 analysts
Hold
Medtech with 56% gross margins whose huge GAAP loss is impairment-driven, but leverage jumped and operating cash flow collapsed 68%.
Teleflex is a diversified medical-device maker with attractive underlying product economics — FY2025 gross margin was 56.2% and operating income was positive at $118M (+14.2%) — but the headline -$906M net loss and -$20.25 EPS reflect a large non-cash impairment rather than an operating collapse. The tell is the gap between the deep net loss and the still-positive operating income and gross profit ($1.12B), plus the fact that operating cash flow, though down sharply, remained positive at $96.7M. The write-down most likely relates to goodwill/intangibles from prior or recent M&A.
Sources: SEC EDGAR (CIK 0000096943, latest 10-Q filed 2026-05-07) · EODHD · analysis by claude-code · as of 6/21/2026, 8:57:44 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.